Browse by Audience
MEMBER

Update Your Profile
Member Spotlights
Refer a Member: IASP Champions
Join a Special Interest Group (SIG)
Find a Chapter
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Papers of the Week
Webinars and Podcasts
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Webinars & Podcasts
Curricula
Graduate Opportunities
Events

PATIENT & CAREGIVER

RELIEF News
Resources for Living with Pain
Global Alliance of Partners in Pain Advocacy (GAPPA)
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner

gy2022-1-3
I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / Review of Ruxolitinib in the Treatment of Atopic Dermatitis.

< BACK TO ARCHIVE


Papers: 4 Jun 2022 - 10 Jun 2022


2022 Jun 08


Ann Pharmacother


http://www.ncbi.nlm.nih.gov/pubmed/35674400?dopt=Abstract

Review of Ruxolitinib in the Treatment of Atopic Dermatitis.

Authors

Review of Ruxolitinib in the Treatment of Atopic Dermatitis.
Mohney LA, Singh R, Feldman SR
Ann Pharmacother. 2022 Jun 08:10600280221103282.
PMID: 35674400.

Abstract

To review the pharmacokinetics, efficacy, and safety of a newly approved topical Janus kinase 1 (JAK) inhibitor, ruxolitinib (RUX), in patients with atopic dermatitis (AD).
Read This Paper